Who are the key players in North America Blood Collection Devices Market industry?

The top five players in the North America Blood Collection Devices Market are Becton, Dickinson and Company (BD), Terumo Corporation, Greiner Bio-One, Medtronic, and Quest Diagnostics. These companies are known for their innovative blood collection technologies, extensive product portfolios, and strong regional presence, driving advancements in healthcare diagnostics.

Which segment accounted for the largest North America Blood Collection Devices Market share?

Hospitals and diagnostic centers held the largest market share in the applications segment. This is due to the high patient influx, extensive use of blood collection devices for disease monitoring, and increasing adoption of advanced diagnostic equipment in these healthcare settings throughout North America.

What are the factors driving the North America Blood Collection Devices Market?

The major drivers include rising prevalence of chronic and infectious diseases, growing demand for minimally invasive diagnostic procedures, and technological advancements as seen with BD’s recent launches of advanced vacuum blood collection systems, improving patient comfort and collection efficiency across healthcare facilities in North America.

Which type accounted for the largest North America Blood Collection Devices Market share?

Vacuum blood collection tubes accounted for the largest market share among types. Their widespread use in routine diagnostics, ability to minimize contamination, and improved safety features have led to their dominance, supported by leading manufacturers like Greiner Bio-One and BD.

Home Healthcare

North America Blood Collection Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Blood Collection Devices Market
Brand: Bussiness Insights

North America Blood Collection Devices Market Market: by Type (Needles and Syringes, Blood Collection Tubes, Lancets, Blood Bags, Vacuum Blood Collection Systems, Others), Application (Diagnostics, Therapeutics, Blood Transfusion, Research, Others), Distribution Channels (Hospitals, Diagnostic Centers, Blood Banks, Ambulatory Surgical Centers, Research & Academic Institutes, Others), Technology (Manual Blood Collection, Automated Blood Collection, Capillary Blood Collection, Plasma Separation Technologies, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20428

North America Blood Collection Devices Market Outlook (2025-2035)

The North America Blood Collection Devices market encompasses a diverse range of products utilized in clinical diagnostics, transfusion, research, and therapeutic applications. With rapid advancement in medical technologies and ongoing demand from healthcare institutions, this market is poised for significant growth. The market is influenced by increases in chronic disease prevalence, growing elderly population, improved healthcare infrastructure, and continuous product innovations from key industry players. The adoption of advanced automation and minimally invasive blood collection techniques further drives the sector. Major device types include needles, syringes, blood collection tubes, vacuum systems, and blood bags, with distribution spanning hospitals, diagnostic centers, blood banks, and more. The market is competitive, with dominance by several multinational companies and continuous new entrants bringing innovation.

Latest Market Dynamics

Key Drivers

Rise in Chronic and Infectious Diseases: The increasing incidence of chronic conditions such as diabetes and cardiovascular ailments as well as infections necessitates frequent blood testing. Companies like

Expansion in Point-of-Care Testing: The surge in decentralized healthcare has elevated demand for capillary blood collection devices and rapid diagnostics kits. Greiner Bio-One International GmbH is actively innovating in this segment to provide compact, user-friendly collection systems for point-of-care settings.
Sustainability Initiatives and Single-Use Devices: Increasing regulatory scrutiny and eco-consciousness push market leaders like Fresenius Kabi AG to produce recyclable or biodegradable blood collection products, aligning with healthcare provider preferences for sustainable operations.

Growth of Home Healthcare and Remote Diagnostics: The rise in telemedicine and home healthcare creates demand for user-friendly, safe, and minimally invasive blood collection kits. Haemonetics Corporation has invested in developing devices compatible with at-home use, improving access for patients with mobility challenges.
Expansion into Emerging Markets within North America: Growing healthcare infrastructure and government investment in Mexico and underserved US regions present expansion opportunities for suppliers such as Cardinal Health, Inc., aiming to broaden product distribution networks and healthcare partnerships.

Stringent Regulatory Approval Processes: Regulatory hurdles can delay time-to-market for novel blood collection devices. Medtronic plc faces continued pressure to meet evolving FDA standards, impacting speed of innovation and adoption.
Product Recalls and Compliance Issues: Quality concerns and device recalls can tarnish reputations and cause financial setbacks. In 2024, Nipro Medical Corporation had to manage a recall incident due to safety non-compliance, which affected stakeholder confidence and sales.

High Cost of Advanced Blood Collection Technologies: The introduction of fully automated and next-generation blood collection systems comes with substantial costs, making affordability a concern for small to mid-size healthcare settings. ICU Medical, Inc. faces challenges in pricing strategies to drive broader adoption.
Limited Awareness and Training for New Devices: Many clinical staff remain unaware or untrained with respect to using newer blood collection systems, impacting market penetration. Smiths Medical is addressing this restraint by providing targeted training and support programs.

In 2025, blood collection tubes dominate the North America market, closely followed by needles and syringes. Blood bags, vacuum blood collection systems, lancets, and others collectively account for a smaller market share. This distribution reflects the essential use of blood collection tubes in diagnostics and research, aligning with increasing routine blood testing and integrated healthcare solutions. Manufacturers focusing on convenience, safety, and contamination prevention continue to invest in tube-based innovations, ensuring reliability for end-users. With regulatory focus on sample quality, tubes remain integral to clinical workflows. Other device types, though vital, cater to more specialized or less frequent collection needs.

Diagnostic applications hold the largest share in the market by application segment for 2025, followed by blood transfusion and therapeutics. Research, population health monitoring, and other sub-segments account for smaller portions. The dominance of diagnostics is attributed to increased prevalence of chronic and infectious diseases, routine health monitoring, and corporate wellness screening. Blood transfusion maintains a significant share due to high demand in hospitals and trauma centers. Therapeutics is steadily rising owing to advances in blood-borne therapies and precision medicine.

From 2020 to 2035, the North America Blood Collection Devices market is projected to experience substantial growth. The market revenue is expected to soar from 3,580 Million in 2021 to 6,730 Million in 2035, reflecting increased demand for blood collection devices driven by advancements in technology, expansion of healthcare infrastructure, and higher blood testing frequency. The upward trend highlights the role of innovation and improved healthcare access, with key companies investing in automation and user-friendly products to drive adoption across diverse settings.

The United States remains the largest market for blood collection devices in North America, accounting for 69% of the total market share in 2025, followed by Canada with an 18% share and Mexico at 13%. This regional distribution reflects the US's dominance in healthcare infrastructure and R&D activities, while Canada and Mexico are steadily increasing their market presence through improved healthcare funding and expanding hospital networks.

Among the key market participants, Becton, Dickinson and Company leads with a 22% share, followed by Terumo Corporation and Greiner Bio-One International GmbH at 15% and 12% respectively. The rest of the market is shared among Fresenius Kabi AG, Haemonetics Corporation, Cardinal Health, and other players. This competitive landscape is characterized by frequent product launches, partnerships, and R&D investments aimed at gaining higher market shares.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	4120
Regions	United States, Canada, Mexico
Segments	Needles and Syringes, Blood Collection Tubes, Lancets, Blood Bags, Vacuum Blood Collection Systems, Others; Diagnostics, Therapeutics, Blood Transfusion, Research, Others, Population Health Monitoring; Manual Blood Collection, Automated Blood Collection, Capillary Blood Collection, Plasma Separation Technologies, Serological Testing Technologies, Others; Hospitals, Diagnostic Centers, Blood Banks, Ambulatory Surgical Centers, Research & Academic Institutes, Others; Small, Medium, Large
Players	Becton, Dickinson and Company, Terumo Corporation, Greiner Bio-One International GmbH, Fresenius Kabi AG, Haemonetics Corporation, Cardinal Health, Inc., Sarstedt AG & Co. KG, Medtronic plc, Nipro Medical Corporation, Smiths Medical, FL Medical S.R.L., Retractable Technologies, Inc., AdvaCare Pharma, Kawasumi Laboratories, Inc., ICU Medical, Inc.

June 2024: Becton, Dickinson and Company launched the BD UltraSafe™ Plus Blood Collection Set featuring enhanced user safety and sample integrity.
July 2024: Terumo Corporation expanded its VACUETTE® Premium line with an innovative closed-system device for high-throughput laboratories.
August 2024: Cardinal Health announced an exclusive partnership with a leading diagnostic network to supply next-gen automated blood collection tubes.
September 2024: Greiner Bio-One received FDA clearance for its eco-friendly, recyclable blood collection tube series in North America.
October 2024: Haemonetics Corporation introduced a new at-home blood collection kit, supporting the shift towards remote diagnostics and telemedicine.

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

North America Blood Collection Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Blood Collection Devices Market Outlook (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

Market Share by Type (2025)

Market Share by Application (2025)

Market Revenue (USD Million, 2020-2035)

Year-on-Year Growth Rate (%) (2020-2035)

Regional Market Share (2025)

Top Players Market Share (2025)

Market Buyers Share (2025)

Study Coverage

Key Recent Developments

Frequently asked questions